| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Syntenins | 12 | 2023 | 12 | 2.680 |
Why?
|
| Interleukins | 10 | 2025 | 112 | 2.150 |
Why?
|
| Neoplasms | 8 | 2021 | 857 | 1.310 |
Why?
|
| Melanoma | 6 | 2023 | 140 | 1.290 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 490 | 1.280 |
Why?
|
| MicroRNAs | 3 | 2019 | 301 | 1.260 |
Why?
|
| Apoptosis | 9 | 2021 | 777 | 1.230 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 282 | 1.120 |
Why?
|
| Proto-Oncogenes | 5 | 2014 | 15 | 1.080 |
Why?
|
| Transcription Factors | 4 | 2014 | 523 | 0.990 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 1338 | 0.920 |
Why?
|
| bcl-X Protein | 3 | 2014 | 35 | 0.890 |
Why?
|
| Animals | 27 | 2025 | 10580 | 0.800 |
Why?
|
| Bone Neoplasms | 2 | 2023 | 29 | 0.770 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 357 | 0.740 |
Why?
|
| Oxadiazoles | 1 | 2021 | 3 | 0.710 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 472 | 0.700 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 45 | 0.690 |
Why?
|
| Mice | 17 | 2025 | 4732 | 0.690 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 681 | 0.680 |
Why?
|
| Beclin-1 | 2 | 2017 | 5 | 0.660 |
Why?
|
| Pyrimidines | 1 | 2021 | 128 | 0.650 |
Why?
|
| Ribonuclease III | 1 | 2019 | 6 | 0.610 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2019 | 7 | 0.610 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 26 | 0.600 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 6 | 0.580 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 274 | 0.550 |
Why?
|
| Humans | 35 | 2025 | 28581 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 155 | 0.530 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 415 | 0.520 |
Why?
|
| Neoplasm Metastasis | 4 | 2023 | 164 | 0.510 |
Why?
|
| Signal Transduction | 7 | 2023 | 1454 | 0.500 |
Why?
|
| Brain Neoplasms | 4 | 2025 | 311 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 465 | 0.480 |
Why?
|
| Autophagy | 4 | 2021 | 74 | 0.470 |
Why?
|
| Triticum | 2 | 2026 | 13 | 0.450 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 13 | 0.440 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 13 | 0.410 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2013 | 10 | 0.410 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 18 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 344 | 0.400 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 141 | 0.380 |
Why?
|
| Glioma | 3 | 2018 | 121 | 0.370 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 290 | 0.370 |
Why?
|
| Down-Regulation | 3 | 2019 | 200 | 0.370 |
Why?
|
| Mice, Nude | 4 | 2024 | 332 | 0.360 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 41 | 0.350 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 4 | 2014 | 4 | 0.330 |
Why?
|
| Tumor Microenvironment | 6 | 2025 | 186 | 0.330 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 190 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 170 | 0.300 |
Why?
|
| Small Molecule Libraries | 2 | 2019 | 19 | 0.300 |
Why?
|
| Disease Resistance | 2 | 2026 | 16 | 0.290 |
Why?
|
| Plant Diseases | 2 | 2026 | 39 | 0.290 |
Why?
|
| Neoplastic Stem Cells | 3 | 2018 | 141 | 0.280 |
Why?
|
| Neuroblastoma | 2 | 2019 | 56 | 0.270 |
Why?
|
| Basidiomycota | 2 | 2026 | 4 | 0.270 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 147 | 0.260 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 404 | 0.260 |
Why?
|
| Glioblastoma | 2 | 2025 | 109 | 0.260 |
Why?
|
| Adenoviridae | 2 | 2024 | 68 | 0.240 |
Why?
|
| Interleukin-15 | 1 | 2025 | 2 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2025 | 233 | 0.220 |
Why?
|
| HEK293 Cells | 3 | 2021 | 188 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 83 | 0.210 |
Why?
|
| Immunotherapy | 1 | 2025 | 160 | 0.200 |
Why?
|
| Integrin beta1 | 1 | 2023 | 15 | 0.200 |
Why?
|
| Inflammation | 2 | 2018 | 641 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2019 | 815 | 0.190 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2019 | 39 | 0.190 |
Why?
|
| Aloe | 1 | 2021 | 1 | 0.180 |
Why?
|
| Anoikis | 2 | 2018 | 3 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 144 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 50 | 0.180 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Chemokine CCL17 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Acetylation | 2 | 2011 | 37 | 0.180 |
Why?
|
| Chemokine CCL11 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Interleukin-1alpha | 1 | 2021 | 7 | 0.180 |
Why?
|
| Interleukin-5 | 1 | 2021 | 8 | 0.180 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 285 | 0.180 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 29 | 0.180 |
Why?
|
| Cell Engineering | 1 | 2021 | 1 | 0.180 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 25 | 0.180 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 14 | 0.170 |
Why?
|
| Peptides | 1 | 2023 | 293 | 0.170 |
Why?
|
| Male | 8 | 2023 | 13771 | 0.170 |
Why?
|
| Tumor Burden | 1 | 2021 | 110 | 0.170 |
Why?
|
| Interleukin-10 | 1 | 2021 | 74 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 2 | 2018 | 97 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 278 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2011 | 247 | 0.170 |
Why?
|
| Female | 8 | 2023 | 15471 | 0.160 |
Why?
|
| Protein Binding | 2 | 2011 | 664 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2019 | 419 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.140 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 4 | 0.140 |
Why?
|
| Disease | 1 | 2018 | 15 | 0.140 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 36 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 20 | 0.140 |
Why?
|
| Oncogenes | 1 | 2017 | 34 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 85 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 546 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2018 | 124 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 111 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 328 | 0.130 |
Why?
|
| Anthraquinones | 1 | 2016 | 4 | 0.130 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 8 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 137 | 0.130 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2016 | 2 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 31 | 0.120 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 15 | 0.120 |
Why?
|
| Sirolimus | 1 | 2016 | 76 | 0.120 |
Why?
|
| Liposomes | 1 | 2016 | 145 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 128 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 29 | 0.110 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 86 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 19 | 0.110 |
Why?
|
| Filariasis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Wuchereria bancrofti | 1 | 2014 | 1 | 0.110 |
Why?
|
| Brugia pahangi | 1 | 2014 | 1 | 0.110 |
Why?
|
| Antigens, Helminth | 1 | 2014 | 11 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2014 | 53 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2016 | 861 | 0.110 |
Why?
|
| Vitamin D | 1 | 2014 | 51 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2014 | 50 | 0.100 |
Why?
|
| SUMO-1 Protein | 1 | 2013 | 1 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 72 | 0.100 |
Why?
|
| Arsenicals | 1 | 2013 | 5 | 0.100 |
Why?
|
| Genotype | 2 | 2026 | 461 | 0.100 |
Why?
|
| Oxides | 1 | 2013 | 14 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2013 | 515 | 0.100 |
Why?
|
| Monocytes | 1 | 2014 | 135 | 0.100 |
Why?
|
| Cell Movement | 3 | 2019 | 373 | 0.090 |
Why?
|
| HT29 Cells | 1 | 2011 | 20 | 0.090 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 14 | 0.090 |
Why?
|
| Zinc Fingers | 1 | 2011 | 26 | 0.090 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 44 | 0.090 |
Why?
|
| Interleukin-6 | 3 | 2018 | 194 | 0.090 |
Why?
|
| K562 Cells | 1 | 2011 | 20 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 137 | 0.090 |
Why?
|
| India | 2 | 2026 | 143 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 509 | 0.080 |
Why?
|
| Dogs | 1 | 2011 | 510 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 104 | 0.080 |
Why?
|
| Cell Death | 2 | 2021 | 119 | 0.080 |
Why?
|
| Base Sequence | 1 | 2011 | 588 | 0.080 |
Why?
|
| Cattle | 1 | 2011 | 388 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1056 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 41 | 0.070 |
Why?
|
| Rats | 1 | 2011 | 1587 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 179 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 595 | 0.070 |
Why?
|
| Carcinogenesis | 2 | 2018 | 81 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 992 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2026 | 53 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 314 | 0.060 |
Why?
|
| Metabolomics | 1 | 2026 | 87 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 233 | 0.060 |
Why?
|
| Microbubbles | 1 | 2024 | 5 | 0.050 |
Why?
|
| Oncolytic Virotherapy | 1 | 2024 | 12 | 0.050 |
Why?
|
| Poly C | 1 | 2023 | 1 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2023 | 57 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2024 | 118 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2023 | 38 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2023 | 47 | 0.050 |
Why?
|
| Plant Breeding | 1 | 2023 | 5 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2023 | 8 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2026 | 550 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 133 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 52 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2021 | 62 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 453 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 56 | 0.040 |
Why?
|
| Transfection | 1 | 2021 | 319 | 0.040 |
Why?
|
| DNA | 1 | 2021 | 375 | 0.040 |
Why?
|
| Integrins | 1 | 2019 | 29 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 770 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2019 | 25 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 27 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 53 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 354 | 0.040 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2018 | 45 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Breast | 1 | 2018 | 52 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 54 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 59 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 5 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 30 | 0.030 |
Why?
|
| Melanocytes | 1 | 2016 | 13 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 27 | 0.030 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 33 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 44 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 52 | 0.030 |
Why?
|
| Caspases | 1 | 2016 | 43 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2016 | 33 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 126 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2016 | 103 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1601 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 337 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 95 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 79 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2014 | 52 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 31 | 0.030 |
Why?
|
| Sumoylation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 380 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 66 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 257 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 114 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 68 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 132 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 291 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 864 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 893 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 667 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 7922 | 0.010 |
Why?
|